PlainPharmaWatch

CMS Open Payments · Program Year 2024

Medacta USA, Inc.

Medacta USA, Inc. reported $10,165,173.98 across General Payments, Research, and Ownership to 6,621 physicians and teaching hospitals across 6,719 transactions.

See the rankings → How this is sourced
$10.2M
All-tracks total
6,719
Transactions
6,621
Recipients
+$2.2M
General Payments vs PY2023

Medacta USA, Inc. reported $10,165,173.98 across all CMS Open Payments tracks (General + Research + Ownership) to 6,621 physicians and teaching hospitals in Program Year 2024 - ranking #173 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $8,407,641.71, averaging $1.5K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer medacta-usa-inc Medacta USA, Inc.

$10.2M · #173/1,925 · 0.1% industry · PY2024

  • TOT $10.2M
  • RANK #173
  • SHARE 0.1%
  • TXN 6,719
  • RCP 6,621
  • CAT 5
  • GEN $8.4M
  • ΔGEN +$2.2M
  • TOP1 21.8%
  • PY 2024

Volume peers

Nearest volume peer: National Marrow Donor Program ($10.2M)

ACADIA Pharmaceuticals Inc$10.2MDigital Diagnostics Inc.$10.2MMedacta USA, Inc. (this)$10.2MNational Marrow Donor Program$10.2MOsteoCentric Technologies, I…$10.1M
All-tracks payment totals near Medacta USA, Inc. (CMS Open Payments PY2024)

Medacta USA, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Medacta USA, Inc.'s CMS-reported General Payments increased by $2.2M (+35.0%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: MEDACTA USA, INC.PY2023: MEDACTA USA, INC.PY2024: MEDACTA USA, INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$6.2MPY2024$8.4M
PY2023
$6,225,608.06
PY2024
$8,407,641.71

What the Data Shows for Medacta USA, Inc.

$10,165,173.98: that is what Medacta USA, Inc. reported in payments to 6,621 physicians and teaching hospitals during Program Year 2024, spread across 6,719 transactions ($1.5K per transaction, $1.5K per recipient). The company sits at rank #173 of 1,925, a comparatively small 0.1% slice of all industry payments reported nationwide for the year.

The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $3.8M, accounting for 45.6% of this company's General Payments and 466 transactions.

General Payment Breakdown by Type

Across 5 types of general payments, Medacta USA, Inc.'s largest category was "Consulting Fee" at $3.8M - 45.6% of General Payments.

Medacta USA, Inc. reports 5 general-payment categories - the top three are Consulting Fee (45.6%), Royalty or License (38.2%), and Travel and Lodging (13.4%). The remaining 2 categories make up 2.9% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.

How Medacta USA, Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$3.8M2. Royalty or License$3.2M3. Travel and Lodging$1.1M4. Food and Beverage$244.5K5. Education$108.73
Payment Type Amount Transactions
Consulting Fee $3.8M 466
Royalty or License $3.2M 417
Travel and Lodging $1.1M 2,251
Food and Beverage $244.5K 3,486
Education $108.73 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $3,013,411.31 (35.8%) of $8,407,641.71 in this company's General Payments records across 1,004 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Medacta USA, Inc.

The five named recipients with the highest reported General Payments from this company

Stephen Howell$1.8MDavid Loucks$317.2KRobert Greenhow$296.1KTyler Goldberg$293.4KMatthew Saltzman$276.0K
  1. 1

    Stephen Howell

    $1,830,706.07 across 144 reported transactions

  2. 2

    David Loucks

    $317,247.89 across 36 reported transactions

  3. 3

    Robert Greenhow

    $296,114.76 across 24 reported transactions

  4. 4

    Tyler Goldberg

    $293,392.58 across 82 reported transactions

  5. 5

    Matthew Saltzman

    $275,950.01 across 76 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Medacta USA, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Medacta USA, Inc..

Kub Technologies Inc.

HHI 583

IlluminOss Medical, Inc.

HHI 583

Accuray Incorporated

HHI 584

CONMED Corporation

HHI 586

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Medacta USA, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Medacta USA, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.